Gemcitabine and Impurities
Ref: 4Z-G-2626
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
LY2334737
CAS:892128-60-8
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
Formula:
C17H25F2N3O5
Purity:
99.4%
Color and Shape:
Solid
Molecular weight:
389.39
Ref: TM-T4061
| 1mg | 69.00 € | ||
| 5mg | 150.00 € | ||
| 10mg | 222.00 € | ||
| 25mg | 368.00 € | ||
| 50mg | 548.00 € | ||
| 100mg | 759.00 € | ||
| 1mL*10mM (DMSO) | 165.00 € |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-G-2654
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Ref: 4Z-G-265
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 26 Nov 2024
Gemcitabine monophosphate
CAS:116371-67-6
R306465, a potent HDAC1/8 inhibitor, has broad antitumor effects (IC50: 30-300 nM) on solid and …
Formula:
C9H12F2N3O7P
Color and Shape:
Solid
Molecular weight:
343.18
Ref: TM-T21329
| 500µg | 270.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
